Current Hypertension Reports

, Volume 13, Issue 3, pp 244–248 | Cite as

Stress and Its Role in Sympathetic Nervous System Activation in Hypertension and the Metabolic Syndrome

Article

Abstract

Stress in several guises is evident in individuals with hypertension and in those with the metabolic syndrome and may account, at least in part, for the extent and pattern of sympathetic nervous activation. Importantly, elevated activity of the sympathetic nervous system is related to the development of obesity-related illnesses including hypertension, insulin resistance, and renal, cardiac, and vascular impairment. Notably, evidence of subclinical organ damage is evident even in young, normotensive, overweight persons, thereby reinforcing the need to develop and implement effective early intervention.

Keywords

Stress Sympathetic nervous system Obesity Metabolic syndrome 

Notes

Acknowledgment

This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC).

Disclosure

The investigators (or their laboratory) have received research funding from commercial sponsors including Abbot (formerly Solvay Pharmaceuticals), Servier, Ardian Inc, Allergan, and Scientific Intake. Dr. Gavin Lambert has received honoraria or travel support for presentations from Servier, Wyeth Pharmaceuticals, and Pfizer. No other potential conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Anagnostis P, Athyros VG, Tziomalos K, et al. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692–701.PubMedCrossRefGoogle Scholar
  2. 2.
    Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol. 2008;51:1237–46.PubMedCrossRefGoogle Scholar
  3. 3.
    Esler M, Eikelis N, Schlaich M, et al. Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol. 2008;35:498–502.PubMedCrossRefGoogle Scholar
  4. 4.
    Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332:521–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Esler M, Jennings G, Lambert G. Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology. 1989;14:477–81.PubMedCrossRefGoogle Scholar
  6. 6.
    Grassi G, Seravalle G, Dell’Oro R, et al. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000;36:538–42.PubMedGoogle Scholar
  7. 7.
    Lambert E, Straznicky N, Eikelis N, et al. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens. 2007;25:1411–9.PubMedCrossRefGoogle Scholar
  8. 8.
    •• Lambert E, Sari CI, Dawood T, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension. 2010;56:351–8. This article documents the association between sympathetic nervous activation and preclinical signs of end-organ damage in young, overweight, yet normotensive individuals, thereby highlighting the need for early detection and possible intervention.PubMedCrossRefGoogle Scholar
  9. 9.
    Rumantir MS, Jennings GL, Lambert GW, et al. The ‘adrenaline hypothesis’ of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens. 2000;18:717–23.PubMedCrossRefGoogle Scholar
  10. 10.
    Micutkova L, Krepsova K, Sabban E, et al. Modulation of catecholamine-synthesizing enzymes in the rat heart by repeated immobilization stress. Ann NY Acad Sci. 2004;1018:424–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Wallin BG, Esler M, Dorward P, et al. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol. 1992;453:45–58.PubMedGoogle Scholar
  12. 12.
    Lucini D, Di Fede G, Parati G, Pagani M. Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension. 2005;46:1201–6.PubMedCrossRefGoogle Scholar
  13. 13.
    • Flaa A, Aksnes TA, Kjeldsen SE, et al. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism. 2008;57:1422–7. Sympathetic reactivity was shown to be predictive of subsequent development of insulin resistance. PubMedCrossRefGoogle Scholar
  14. 14.
    Marmot MG, Bosma H, Hemingway H, et al. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet. 1997;350:235–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:953–62.PubMedCrossRefGoogle Scholar
  16. 16.
    Bjorntorp P. Neuroendocrine abnormalities in human obesity. Metabolism. 1995;44:38–41.PubMedCrossRefGoogle Scholar
  17. 17.
    Vicennati V, Pasqui F, Cavazza C, et al. Stress-related development of obesity and cortisol in women. Obesity (Silver Spring). 2009;17:1678–83.CrossRefGoogle Scholar
  18. 18.
    Zhang J, Niaura R, Dyer JR, et al. Hostility and urine norepinephrine interact to predict insulin resistance: the VA normative aging study. Psychosom Med. 2006;68:718–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Fowler-Brown AG, Bennett GG, Goodman MS, et al. Psychosocial stress and 13-year BMI change among blacks: the Pitt county study. Obesity (Silver Spring). 2009;17:2106–9.CrossRefGoogle Scholar
  20. 20.
    Block JP, He Y, Zaslavsky AM, et al. Psychosocial stress and change in weight among US adults. Am J Epidemiol. 2009;170:181–92.PubMedCrossRefGoogle Scholar
  21. 21.
    van Jaarsveld CH, Fidler JA, Steptoe A, et al. Perceived stress and weight gain in adolescence: a longitudinal analysis. Obesity (Silver Spring). 2009;17:2155–61.CrossRefGoogle Scholar
  22. 22.
    Zhao G, Ford ES, Dhingra S, et al. Depression and anxiety among US adults: associations with body mass index. Int J Obes (Lond). 2009;33:257–66.CrossRefGoogle Scholar
  23. 23.
    Kopf D, Westphal S, Luley CW, et al. Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol. 2004;24:527–31.PubMedCrossRefGoogle Scholar
  24. 24.
    Ljung T, Ahlberg AC, Holm G, et al. Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study. J Intern Med. 2001;250:219–24.PubMedCrossRefGoogle Scholar
  25. 25.
    Barton DA, Dawood T, Lambert EA, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens. 2007;25:2117–24.PubMedCrossRefGoogle Scholar
  26. 26.
    Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Vogelzangs N, Suthers K, Ferrucci L, et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007;32:151–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Vogelzangs N, Kritchevsky SB, Beekman AT, et al. Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 2008;65:1386–93.PubMedCrossRefGoogle Scholar
  29. 29.
    Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 2007;62:1251–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Lambert GW, Straznicky NE, Lambert EA, et al. Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol Ther. 2010;126:159–72.PubMedCrossRefGoogle Scholar
  31. 31.
    Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. 2007;13:803–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Morris MJ, Cox HS, Lambert GW, et al. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension. 1997;29:137–43.PubMedGoogle Scholar
  33. 33.
    Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560–3.PubMedGoogle Scholar
  34. 34.
    Straznicky NE, Lambert EA, Lambert GW, et al. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab. 2005;90:5998–6005.PubMedCrossRefGoogle Scholar
  35. 35.
    Straznicky NE, Eikelis N, Lambert EA, Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep. 2008;10:440–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Lambert E, Straznicky N, Schlaich M, et al. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension. 2007;50:862–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106:2533–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Straznicky NE, Grima MT, Eikelis N, et al: The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab 2010 Dec 22 (Epub ahead of print).Google Scholar
  39. 39.
    Mathieu P, Poirier P, Pibarot P, et al. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension. 2009;53:577–84.PubMedCrossRefGoogle Scholar
  40. 40.
    Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res. 2006;29:839–47.PubMedCrossRefGoogle Scholar
  41. 41.
    Wirtz PH, Ehlert U, Bartschi C, et al. Changes in plasma lipids with psychosocial stress are related to hypertension status and the norepinephrine stress response. Metabolism. 2009;58:30–7.PubMedCrossRefGoogle Scholar
  42. 42.
    •• Lambert E, Dawood T, Straznicky N, et al. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens. 2010;28:543–50. This paper highlights the importance of psychosocial stress in influencing the pattern of sympathetic nerve firing. PubMedCrossRefGoogle Scholar
  43. 43.
    Lambert E, Hotchkin E, Alvarenga M, et al. Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. J Physiol. 2006;570:637–43.PubMedCrossRefGoogle Scholar
  44. 44.
    Lambert E, Dawood T, Schlaich M, et al. Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol. 2008;35:503–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Macefield VG, Rundqvist B, Sverrisdottir YB, et al. Firing properties of single muscle vasoconstrictor neurons in the sympathoexcitation associated with congestive heart failure. Circulation. 1999;100:1708–13.PubMedGoogle Scholar
  46. 46.
    Shibao C, Gamboa A, Diedrich A, et al. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49:27–33.PubMedCrossRefGoogle Scholar
  47. 47.
    Rumantir MS, Vaz M, Jennings GL, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17:1125–33.PubMedCrossRefGoogle Scholar
  48. 48.
    Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932–4.PubMedCrossRefGoogle Scholar
  49. 49.
    Straznicky NE, Lambert EA, Nestel PJ, et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes. 2010;59:71–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Human Neurotransmitters LaboratoryBaker IDI Heart & Diabetes InstituteMelbourneAustralia

Personalised recommendations